Billiontoone (NASDAQ:BLLN) Trading Down 5.6% – Here’s Why

Billiontoone, Inc. (NASDAQ:BLLN)’s stock price was down 5.6% during trading on Monday . The stock traded as low as $124.01 and last traded at $122.9510. 146,159 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 492,120 shares. The stock had previously closed at $130.31.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on BLLN. BTIG Research reduced their price objective on Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. JPMorgan Chase & Co. raised their target price on Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Weiss Ratings raised Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, June 23rd. Finally, Guggenheim initiated coverage on Billiontoone in a research report on Monday, June 29th. They set a “buy” rating and a $125.00 price target for the company. Six research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $126.00.

Billiontoone Stock Performance

The company has a quick ratio of 10.58, a current ratio of 10.92 and a debt-to-equity ratio of 0.18. The stock has a market cap of $6.10 billion and a price-to-earnings ratio of 240.96. The company’s 50-day simple moving average is $105.93 and its 200-day simple moving average is $90.90.

Billiontoone (NASDAQ:BLLN) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.33. The company had revenue of $108.39 million during the quarter, compared to the consensus estimate of $95.81 million. Billiontoone’s quarterly revenue was up 83.8% on a year-over-year basis. During the same period in the prior year, the company posted ($0.39) EPS. Analysts predict that Billiontoone, Inc. will post 0.92 EPS for the current fiscal year.

Insider Activity at Billiontoone

In other news, SVP Bosch John Roderick Ten sold 1,416 shares of the company’s stock in a transaction on Monday, June 29th. The stock was sold at an average price of $120.00, for a total transaction of $169,920.00. Following the completion of the sale, the senior vice president directly owned 33,552 shares of the company’s stock, valued at $4,026,240. This represents a 4.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nancy Joann Johnson sold 801 shares of the stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $124.91, for a total value of $100,052.91. Following the completion of the transaction, the insider owned 21,099 shares of the company’s stock, valued at $2,635,476.09. This trade represents a 3.66% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 153,049 shares of company stock valued at $16,768,021 over the last ninety days. Company insiders own 50.22% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in BLLN. Rossby Financial LCC purchased a new stake in shares of Billiontoone in the 4th quarter valued at approximately $25,000. Wells Fargo & Company MN purchased a new position in Billiontoone during the 4th quarter worth approximately $76,000. Smartleaf Asset Management LLC acquired a new stake in Billiontoone during the 4th quarter valued at $80,000. Nano Cap New Millennium Growth Fund L P acquired a new stake in Billiontoone during the 4th quarter valued at $82,000. Finally, Renaissance Capital LLC purchased a new stake in shares of Billiontoone in the fourth quarter valued at $201,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.